A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention

Jakub Gumprecht, Magdalena Domek, Gregory Y H Lip

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
Original languageEnglish
JournalExpert Opinion on Drug Safety
Volume18
Issue number12
Pages (from-to)1119-1125
Number of pages7
ISSN1474-0338
DOIs
Publication statusPublished - Dec 2019

Keywords

  • Atrial fibrillation
  • acute coronary syndrome
  • anticoagulation
  • apixaban
  • bleeding
  • compliance
  • efficacy
  • percutaneous coronary intervention
  • pulmonary embolism
  • safety
  • stroke
  • thromboembolism
  • thrombosis

Fingerprint Dive into the research topics of 'A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention'. Together they form a unique fingerprint.

Cite this